1. Home
  2. NWTG vs RNAZ Comparison

NWTG vs RNAZ Comparison

Compare NWTG & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Newton Golf Company Inc. Common Stock

NWTG

Newton Golf Company Inc. Common Stock

HOLD

Current Price

$1.85

Market Cap

7.1M

ML Signal

HOLD

Logo TransCode Therapeutics Inc.

RNAZ

TransCode Therapeutics Inc.

N/A

Current Price

$8.57

Market Cap

8.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NWTG
RNAZ
Founded
2018
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.1M
8.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
NWTG
RNAZ
Price
$1.85
$8.57
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$280.00
AVG Volume (30 Days)
173.3K
9.6K
Earning Date
11-13-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,931,000.00
N/A
Revenue This Year
$120.41
N/A
Revenue Next Year
$70.24
N/A
P/E Ratio
N/A
N/A
Revenue Growth
178.24
N/A
52 Week Low
$0.82
$6.15
52 Week High
$49.80
$468.44

Technical Indicators

Market Signals
Indicator
NWTG
RNAZ
Relative Strength Index (RSI) 67.16 37.41
Support Level $1.49 $8.20
Resistance Level $1.75 $9.41
Average True Range (ATR) 0.18 0.45
MACD 0.08 0.07
Stochastic Oscillator 91.02 31.67

Price Performance

Historical Comparison
NWTG
RNAZ

About NWTG Newton Golf Company Inc. Common Stock

Newton Golf Co Inc is a technology-forward golf company dedicated to revolutionizing the sport with cutting-edge, high-performance products. The company's expanding portfolio includes golf shafts, putters, grips, and other golf-related accessories designed for golfers of all skill levels. The company sells its products through e-commerce, distributors, wholesale customers, including pro-shops at golf courses and off-course retailers, sporting goods retailers, online retailers, third-party distributors, and through Club Champion Golf, as well as through mass merchants and corporate customers in the Americas, Asia, and Europe.

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.

Share on Social Networks: